CBS 2019
CBSMD教育中心
English

动脉粥样硬化性心血管疾病

科研文章

荐读文献

Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis Negative Risk Markers for Cardiovascular Events in the Elderly Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER Trial

Clinical Trial2011;364:818-28.

JOURNAL:N Engl J Med. Article Link

Long-term effects of intensive glucose lowering on cardiovascular outcomes

ACCORD Study Group, HC Gerstein, ME Miller et al. Keywords: T2DM; intensive glucose lowering; cardiovascular effect

Full Text PDF

网站资料更新中...